Antiviral Agents

"Antiviral Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly.

Descriptor ID	D000998
MeSH Number(s)	D27.505.954.122.388
Concept/Terms	Antiviral Agents Antiviral Agents Agents, Antiviral Antivirals Antiviral Drugs Drugs, Antiviral

Below are MeSH descriptors whose meaning is more general than "Antiviral Agents".

Chemicals and Drugs [D]
Chemical Actions and Uses [D27]
Pharmacologic Actions [D27.505]
Therapeutic Uses [D27.505.954]
Anti-Infective Agents [D27.505.954.122]
Antiviral Agents [D27.505.954.122.388]

Below are MeSH descriptors whose meaning is related to "Antiviral Agents".

Below are MeSH descriptors whose meaning is more specific than "Antiviral Agents".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Antiviral Agents" by people in this website by year, and whether "Antiviral Agents" was a major or minor topic of these publications.

Bar chart showing 144 publications over 28 distinct years, with a maximum of 13 publications in 2020

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1997	2	0	2
1998	1	0	1
2000	1	1	2
2002	2	1	3
2003	1	3	4
2004	3	1	4
2005	2	2	4
2006	2	1	3
2007	1	0	1
2008	3	0	3
2009	2	1	3
2010	4	0	4
2011	5	4	9
2012	5	0	5
2013	1	1	2
2014	3	3	6
2015	2	2	4
2016	7	4	11
2017	6	1	7
2018	3	0	3
2019	4	2	6
2020	8	5	13
2021	5	4	9
2022	1	6	7
2023	1	9	10
2024	6	3	9
2025	4	3	7
2026	2	0	2

Below are the most recent publications written about "Antiviral Agents" by people in Profiles.

Mallick S, Sharma P, Yadavalli T, Koganti R, Singh SK, Yoshimura K, Kapoor D, Sutar Y, Adams JS, Annaji M, Shukla D, Date AA. Topical administration of in situ gelling formulation containing myricetin-polycarboxylate nanoparticles inhibits murine genital herpes infection. Int J Pharm. 2026 Apr 25; 695:126672.

View in: PubMed
Adeyinka OS, Metibemu DS, Hampton T, Ojobor JC, Crown O, Falode J, Barrera MD, Alem F, Narayanan A, Ogungbe IV. Broad-spectrum inhibitor of non-structural protein 2 protease shows therapeutic efficacy against Venezuelan equine encephalitis viral infection. Eur J Med Chem. 2026 Apr 15; 308:118696.

View in: PubMed
Esposito N, Viceconte G, Festa L, Alf? FA, Carriero C, Codella AV, Glielmo A, Forgione L, Buonomo AR, Muccio FC, Lamberti M, Alfano R, Coppola MG, Megna AS, Gentile I. Outbreak of Human Neuroinvasive West Nile Virus Infection in Campania, Italy, August-September 2024. Vector Borne Zoonotic Dis. 2025 Sep; 25(9):565-567.

View in: PubMed
Kim J, Lim JW, Kim HO, Park J, Jeong E, Park C, Park G, Yeom M, Song D, Lim EK, Haam S. Hemagglutinin docking analysis-based visual detection of antiviral therapeutic efficacy of umifenovir against influenza virus. Biosens Bioelectron. 2025 Nov 01; 287:117762.

View in: PubMed
Yadav R, Chaudhary AA, Srivastava U, Gupta S, Rustagi S, Rudayni HA, Kashyap VK, Kumar S. Mpox 2022 to 2025 Update: A Comprehensive Review on Its Complications, Transmission, Diagnosis, and Treatment. Viruses. 2025 05 25; 17(6).

View in: PubMed
Sharma T, Mondal T, Saralamma VVG, Hassan MI, Kim CJ, Churqui MP, Nystr?m K, Thombare K, Baig MH, Dong JJ. Exploring the exportin-1 inhibitors for COVID-19 and anticancer treatment. J Biomol Struct Dyn. 2026 Jan; 44(1):463-474.

View in: PubMed
Kashikar R, Kotha AK, Shrestha R, Channappanavar R, Chougule MB. Formulation and In-Vitro Testing of Nebulized Camostat Mesylate Loaded Nanoliposomes for the Treatment of SARS-CoV- 2 Infection. AAPS PharmSciTech. 2025 May 16; 26(5):139.

View in: PubMed
Uwamahoro H, Collier WE, Nashar TO, Jaynes JM, Mortley DG, Davis CG, Kanyairita GG, Abdelazim EF, Igiramaboko JFR, Habineza C, Tumushimiyimana D, Rutayisire UN, Davis YA, Renard KL. Natural and Designed Cyclic Peptides as Potential Antiviral Drugs to Combat Future Coronavirus Outbreaks. Molecules. 2025 Apr 08; 30(8).

View in: PubMed
Maison DP, Tasissa H, Deitchman A, Peluso MJ, Deng Y, Miller FD, Henrich TJ, Gerschenson M. COVID-19 clinical presentation, management, and epidemiology: a concise compendium. Front Public Health. 2025; 13:1498445.

View in: PubMed
Adeyinka OS, Barrera MD, Metibemu DS, Boghdeh N, Anderson CA, Baha H, Crown O, Falode JA, Bleach JL, Bliss AR, Hampton TP, Ojobor JC, Alem F, Narayanan A, Ogungbe IV. nsP2 Protease Inhibitor Blocks the Replication of New World Alphaviruses and Offer Protection in Mice. ACS Infect Dis. 2025 Jan 10; 11(1):181-196.

View in: PubMed

People

Explore

Similar Concepts

Top Journals